1. Home
  2. QDEL

QDEL

QuidelOrtho Corporation

Logo QuidelOrtho Corporation

Health Care

Medical Specialities

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

Founded: 1979 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 2.8B IPO Year: N/A
Target Price: $61.60 AVG Volume (30 days): 1.1M
Analyst Decision: Hold Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.15 EPS Growth: N/A
52 Week Low/High: $41.75 - $98.67 Next Earning Date: 05-01-2024
Revenue: $2,997,800,000 Revenue Growth: -8.21%
Revenue Growth (this year): 0.97% Revenue Growth (next year): -4.96%

Share on Social Networks: